Novel coronavirus"Omicron subtype variant strain BA.2":The latest research progress  

作　　者：You-Cheng Xie Yin-Nan Kang Chun Gao Shan-Shan Liu Li-Ting Zheng Xiao-Hui Yu Jiu-Cong Zhang 

机构地区：[1]The First Clinical Medical School,Gansu University of Chinese Medicine,Lanzhou 730000,China [2]Department of Gastroenterology,The 940 Hospital of Joint Service Support Forces of the Chinese People's Liberation Army,Lanzhou 730050,China

出　　处：《Journal of Hainan Medical University》2022年第8期1-4,共4页海南医学院学报（英文版）

基　　金：The 940th Hospital Intra-Hospital Fund Project(No.20yjky020);the Huoshenshan Hospital Research Fund General Project(No.HSS-217)。

摘　　要：Since the outbreak of COVID-19,with the emergence of a series of novel coronavirus variants of different types,COVID-19 has continued to spread across the globe,posing a huge threat to the lives and health of people around the world and posing a severe challenge to global public health security.Recently,the World Health Organization(WHO)announced that novel coronavirus variant strain"Omicron"subtype variant strain BA.2 has been found in 57 countries and regions.It has higher vaccine and antibody tolerance and is more infectious than omicron(B.1.1.529).In this paper,we briefly review the recent studies on the omicron subtype variant strain BA.2.

关 键 词：Novel coronavirus pneumonia SARS-CoV-2 VARIANTS Omicron BA.2 Progress 

分 类 号：R37[医药卫生—病原生物学]